Tokyo Tape
Sign in
← Em Systems

Quarterly report · Q2

4820.TEDINET S100RMQZ
Period2023-01-01 → 2023-06-30
Filed2023-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥9.8bn2023-01-01 → 2023-06-30Cons.Net sales
Revenue¥16.9bn2022-01-01 → 2022-12-31Cons.Net sales (5-year summary)
Revenue¥8.2bn2022-01-01 → 2022-06-30Cons.Net sales
Operating income¥1.1bn2023-01-01 → 2023-06-30Cons.Operating income
Operating income¥1.4bn2022-01-01 → 2022-06-30Cons.Operating income
Ordinary income¥1.4bn2023-01-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥2.8bn2022-01-01 → 2022-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.6bn2022-01-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥1.2bn2023-01-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥1.6bn2022-01-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥789m2023-01-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.9bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.1bn2022-01-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥784m2023-01-01 → 2023-06-30Cons.Profit loss
Net income¥1.1bn2022-01-01 → 2022-06-30Cons.Profit loss
Total assets¥27.2bnat 2023-06-30Cons.Assets
Total assets¥26.3bnat 2022-12-31Cons.Assets
Total assets¥24.8bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥7.3bnat 2023-06-30Cons.Liabilities
Total liabilities¥6.8bnat 2022-12-31Cons.Liabilities
Net assets / equity¥19.9bnat 2023-06-30Cons.Net assets
Net assets / equity¥19.5bnat 2022-12-31Cons.Net assets
Net assets / equity¥19.1bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥6.4bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥8.9bnat 2022-12-31Cons.Cash and deposits
Cash & equivalents¥6.4bnat 2023-06-30Cons.Cash and cash equivalents
Cash & equivalents¥8.9bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥8.4bnat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥8.3bnat 2021-12-31dCons.Cash and cash equivalents
Operating cash flow¥371m2023-01-01 → 2023-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥2.5bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.3bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥2.2bn2023-01-01 → 2023-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥577m2022-01-01 → 2022-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥295m2022-01-01 → 2022-06-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥661m2023-01-01 → 2023-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.3bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥876m2022-01-01 → 2022-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥11.172023-01-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥3.922023-04-01 → 2023-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥26.752022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥15.352022-01-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥7.422022-04-01 → 2022-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥11.132023-01-01 → 2023-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥26.662022-01-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥15.312022-01-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio72.8%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio73.7%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio76.6%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 42
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-06-30−¥58m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-06-30−¥58m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-06-30¥27m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue2023-01-01 → 2023-06-30¥278m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue external2023-01-01 → 2023-06-30¥278m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentsegment profit2023-01-01 → 2023-06-30−¥285m
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue2023-01-01 → 2023-06-30¥1.5bn
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue external2023-01-01 → 2023-06-30¥1.5bn
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentsegment profit2023-01-01 → 2023-06-30−¥7m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue2023-01-01 → 2023-06-30¥386m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue external2023-01-01 → 2023-06-30¥337m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue intersegment2023-01-01 → 2023-06-30¥48m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentsegment profit2023-01-01 → 2023-06-30¥5m
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue2023-01-01 → 2023-06-30¥7.7bn
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue external2023-01-01 → 2023-06-30¥7.7bn
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue intersegment2023-01-01 → 2023-06-30¥9m
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentsegment profit2023-01-01 → 2023-06-30¥1.4bn
—segment totalrevenue2023-01-01 → 2023-06-30¥9.9bn
—segment totalrevenue external2023-01-01 → 2023-06-30¥9.8bn
—segment totalrevenue intersegment2023-01-01 → 2023-06-30¥58m
—segment totalsegment profit2023-01-01 → 2023-06-30¥1.1bn
Reconciling Itemsreconcilingrevenue2022-01-01 → 2022-06-30−¥24m
Reconciling Itemsreconcilingrevenue intersegment2022-01-01 → 2022-06-30−¥24m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-06-30¥15m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥268m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥268m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentsegment profit2022-01-01 → 2022-06-30¥55m
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥1.1bn
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥1.1bn
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥184m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥347m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥328m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue intersegment2022-01-01 → 2022-06-30¥19m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥22m
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥6.5bn
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥6.5bn
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue intersegment2022-01-01 → 2022-06-30¥5m
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentsegment profit2022-01-01 → 2022-06-30¥1.5bn
—segment totalrevenue2022-01-01 → 2022-06-30¥8.2bn
—segment totalrevenue external2022-01-01 → 2022-06-30¥8.2bn
—segment totalrevenue intersegment2022-01-01 → 2022-06-30¥24m
—segment totalsegment profit2022-01-01 → 2022-06-30¥1.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 541
ItemContextValueUnit
Repayments of lease obligations fin cfPrior1YTDDuration-36000000JPY
Repayments of lease obligations fin cfCurrentYTDDuration-35000000JPY
Purchase of treasury stock fin cfPrior1YTDDuration-344000000JPY
Purchase of treasury stock fin cfCurrentYTDDuration－JPY
Cash dividends paid fin cfPrior1YTDDuration-496000000JPY
Cash dividends paid fin cfCurrentYTDDuration-565000000JPY
Net cash provided by used in financing activitiesPrior1YTDDuration-876000000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration-661000000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YTDDuration43000000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration22000000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration129000000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration-2435000000JPY
Cash and cash equivalentsPrior2YearInstant8289000000JPY
Cash and cash equivalentsPrior1YearInstant8881000000JPY
Decrease in cash and cash equivalents resulting from exclusion of subsidiaries from consolidation ccePrior1YTDDuration－JPY
Decrease in cash and cash equivalents resulting from exclusion of subsidiaries from consolidation cceCurrentYTDDuration－JPY
Cash and cash equivalentsPrior1QuarterInstant8418000000JPY
Cash and cash equivalentsCurrentQuarterInstant6445000000JPY
Salaries and allowances sgaPrior1YTDDuration1215000000JPY
Salaries and allowances sgaCurrentYTDDuration1390000000JPY
Provision for bonuses sgaPrior1YTDDuration222000000JPY
Provision for bonuses sgaCurrentYTDDuration253000000JPY
Retirement benefit expenses sgaPrior1YTDDuration54000000JPY
Retirement benefit expenses sgaCurrentYTDDuration28000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember6494000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember1072000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember268000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E05155-000OtherBusinessReportableSegmentsMember328000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember8164000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration8164000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember5000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E05155-000OtherBusinessReportableSegmentsMember19000000JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember24000000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-24000000JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember6500000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember1072000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember268000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E05155-000OtherBusinessReportableSegmentsMember347000000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember8189000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-24000000JPY
Net salesPrior1YTDDuration8164000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember1496000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember-184000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember55000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E05155-000OtherBusinessReportableSegmentsMember-22000000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember1345000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-01-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass